Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 55, Issue 4, Pages 885-904
Publisher
Springer Nature
Online
2012-01-26
DOI
10.1007/s00125-011-2446-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors
- (2016) Nimer Assy et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
- (2011) Kristin D Kistler et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of antioxidant supplementation on insulin sensitivity in response to endurance exercise training
- (2011) Christina Yfanti et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Obesity, diabetes mellitus, and liver fibrosis
- (2011) Dian J. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
- (2011) V. Nobili et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
- (2011) P. K. Shah et al. DIABETES OBESITY & METABOLISM
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
- (2011) K. Hallsworth et al. GUT
- Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects
- (2011) Sven Haufe et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
- (2011) Ayaka Hamabe et al. JOURNAL OF GASTROENTEROLOGY
- 876 TREATMENT OF NONALCOHOLIC STEATOHEPATITIS WITH PROBIOTICS – A PROOF-OF-CONCEPT STUDY WITH SERIAL GUT MICROBIOTA ANALYSIS BY ULTRA-DEEP SEQUENCING
- (2011) V.W.-S. Wong et al. JOURNAL OF HEPATOLOGY
- 868 EFFICACY OF EZETIMIBE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, CONTROLLED TRIAL
- (2011) Y. Takeshita et al. JOURNAL OF HEPATOLOGY
- 17 DISSOCIATED HISTOLOGICAL AND METABOLIC EFFECTS OF OMEGA-3 (3000 MG/D) VERSUS PLACEBO WITH BOTH EXERCISE AND DIET IN A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF NASH
- (2011) S.H. Caldwell et al. JOURNAL OF HEPATOLOGY
- Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
- (2011) Elena Sofer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals
- (2011) R. Rabol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
- (2010) Temitope Foster et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?
- (2010) Filip K. Knop AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
- (2010) Giovanni Musso et al. Annual Review of Medicine
- Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities
- (2010) Roberto Gambino et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome
- (2010) Sridevi Devaraj et al. Current Atherosclerosis Reports
- Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
- (2010) M. Lazo et al. DIABETES CARE
- Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes
- (2010) J. T. Jonker et al. DIABETES CARE
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
- (2010) D. C. Chan et al. DIABETES CARE
- Combined cardiovascular and diabetes risk assessment in primary care
- (2010) D. Preiss et al. DIABETIC MEDICINE
- Smoking is associated with histological severity in nonalcoholic steatohepatitis
- (2010) Emmanuel A. Tsochatzis et al. HEPATOLOGY
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data
- (2010) Nazim Ghouri et al. HEPATOLOGY
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Need for a three-focused approach to nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review
- (2010) Kota J Reddy et al. Journal of Cardiovascular Medicine
- Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
- (2010) Elisa Fabbrini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
- (2010) Claudia O. Zein et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Antioxidant Supplementation Does Not Alter Endurance Training Adaptation
- (2010) CHRISTINA YFANTI et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
- (2009) E. VILAR GOMEZ et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes
- (2009) Kim-Anne Lê et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
- (2009) J. Jendle et al. DIABETES OBESITY & METABOLISM
- Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients
- (2009) Helma P. Cotrim et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
- (2009) Ziya Omer et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Dietary Fat and Carbohydrates Differentially Alter Insulin Sensitivity During Caloric Restriction
- (2009) Erik Kirk et al. GASTROENTEROLOGY
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis
- (2009) Amalia Gastaldelli et al. HEPATOLOGY
- Independent effects of physical activity in patients with nonalcoholic fatty liver disease
- (2009) Alexis St. George et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
- (2009) Manal F. Abdelmalek et al. HEPATOLOGY
- Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
- (2009) Nathan A. Johnson et al. HEPATOLOGY
- Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
- (2009) Andrea J. Cussons et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
- (2009) Alok K. Gupta et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease
- (2009) Yasuji Arase et al. JOURNAL OF GASTROENTEROLOGY
- Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
- (2009) Yuichi Nozaki et al. JOURNAL OF HEPATOLOGY
- 57 EFFECTS OF FENOFIBRATE AND LONG-ACTING NICOTINIC ACID ON INTRAHEPATIC TRIGLYCERIDE CONTENT AND ADIPOSE TISSUE INSULIN SENSITIVITY IN OBESE HUMAN SUBJECTS
- (2009) K. Korenblat et al. JOURNAL OF HEPATOLOGY
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Corrigendum to: “Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development” [January 2010; Vol. 52, Issue 1, Pages 72-78]
- (2009) Shingo Nakamoto et al. JOURNAL OF HEPATOLOGY
- Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease
- (2009) James Frith et al. JOURNAL OF HEPATOLOGY
- Diet and Exercise Interventions Reduce Intrahepatic Fat Content and Improve Insulin Sensitivity in Obese Older Adults
- (2009) Krupa Shah et al. Obesity
- Antioxidants prevent health-promoting effects of physical exercise in humans
- (2009) M. Ristow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
- (2009) Eugen Florin Georgescu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
- (2009) William W. Shields et al. Therapeutic Advances in Gastroenterology
- The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
- (2008) A. Nar et al. ACTA DIABETOLOGICA
- Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
- (2008) R. IDILMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
- (2008) Shuqin Zheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
- (2008) Valerio Nobili et al. HEPATOLOGY
- Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study
- (2008) Shira Zelber-Sagi et al. HEPATOLOGY
- Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
- (2008) Winston Dunn et al. HEPATOLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
- (2008) Kristiaan Wouters et al. HEPATOLOGY
- A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)
- (2008) Yin-Mei Lee et al. Hepatology International
- The Effect of a Probiotic on Hepatic Steatosis
- (2008) Steven F. Solga et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease
- (2008) Xiaosen Ouyang et al. JOURNAL OF HEPATOLOGY
- Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
- (2008) Kenichiro Yasutake et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
- (2008) Feng-Shang Zhu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
- (2007) Ranganath Muniyappa et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
- (2007) L. Spadaro et al. DIGESTIVE AND LIVER DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started